Fig. 3: sDCTR-miRNAs modify DCT response of PCa cells by regulating PPP2CB and INSIG1.

Cell proliferation after PPP2CB (A), INSIG1 (B), and INSIG2 (D) silencing in treated (with increasing DCT doses) compared to untreated samples. C Relative INSIG2 mRNA quantification by qRT-PCR after miR-96-5p overexpression in treated (3 nM) compared to untreated samples. E FASN, ACLY, and HMGCR mRNAs relative quantification by qRT-PCR after INSIG1 silencing or miR-183-5p or miR-210-3p overexpression in treated (3 nM DCT) compared to untreated samples. F Kaplan–Meier curves showing progression-free interval (PFI) relative to patients stratified by PPP2CB and INSIG1 expression level (high/low according to 0.5 quantile of log2(x + 1)). Log-rank test’s p-value is shown. Data are reported as mean ± SD of at least three independent experiments, *P < 0.05, **P < 0.01, ***P < 0.001 unpaired t-test (A–E).